Marksans Pharma LimitedNSE: MARKSANS

Press Release Oct 15 2025

· Issued by Marksans Pharma Limited

Filed with NSE ·

On 6ix: 6ix.com/news/press-release-oct-15-2025-25

Marksans Pharma Limited has informed the Exchange regarding a press release dated October 15, 2025, titled "Marksans Pharma Ltd's wholly owned subsidiary Relonchem Limited receives Marketing Authorisation for its products from UK MHRA".

View Attachment

6ix hasn’t read this filing yet.

Marksans Pharma Limited on 6ix

Earlier from Marksans Pharma

Later from Marksans Pharma

All Marksans Pharma news releases